The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Halal project offers free course
- Aluminum alloy tops Bahrain’s non-oil exports
- Gulfood: Strong market, expansion boost sales
- Brazil-Arab Gallery #47
- Grand Egyptian Museum: Past and present ‘live’
- After census, Iraq to launch population programs
- Libya: Central Bank to distribute income support
- Syria welcomes 80% more tourists in 2025
